1. Kilpatrick J (2020) Beanie Coffee. https://www.beaniecoffee.com/top-coffee-consuming-countries-world/.
2. Williamson G (2020) Protection against developing type 2 diabetes by coffee consumption: assessment of the role of chlorogenic acid and metabolites on glycaemic responses. Food Funct 11: 4826-4833. doi: 10.1039/d0fo01168a
3. Chen C,Wu F (2017) The need to revisit ochratoxin A risk in light of diabetes, obesity, and chronic kidney disease prevalence. Food Chem Toxicol 103: 79-85. doi: 10.1016/j.fct.2017.03.001
4. Olechno E, Puścion-Jakubik A, Markiewicz-Żukowska R,Socha K (2020) Impact of Brewing Methods on Total Phenolic Content (TPC) in Various Types of Coffee. Molecules 25. doi: 10.3390/molecules25225274
5. Choi Y, Chang Y, Ryu S, Cho J, Rampal S, Zhang Y, Ahn J, Lima JA, Shin H,Guallar E (2015) Coffee consumption and coronary artery calcium in young and middle-aged asymptomatic adults. Heart 101: 686-91. doi: 10.1136/heartjnl-2014-306663
6. Kokubo Y, Iso H, Saito I, Yamagishi K, Yatsuya H, Ishihara J, Inoue M,Tsugane S (2013) The impact of green tea and coffee consumption on the reduced risk of stroke incidence in Japanese population: the Japan public health center-based study cohort. Stroke 44: 1369-74. doi: 10.1161/strokeaha.111.677500
7. O'Keefe JH, DiNicolantonio JJ,Lavie CJ (2018) Coffee for Cardioprotection and Longevity. Prog Cardiovasc Dis 61: 38-42. doi: 10.1016/j.pcad.2018.02.002
8. Benn M,Nordestgaard BG (2018) From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment. Cardiovasc Res 114: 1192-1208. doi: 10.1093/cvr/cvy045
9. Alperet DJ, Rebello SA, Khoo EY, Tay Z, Seah SS, Tai BC, Tai ES, Emady-Azar S, Chou CJ, Darimont C, et al. (2020) The effect of coffee consumption on insulin sensitivity and other biological risk factors for type 2 diabetes: a randomized placebo-controlled trial. Am J Clin Nutr 111: 448-458. doi: 10.1093/ajcn/nqz306
10. Karusheva Y, Kunstein L, Bierwagen A, Nowotny B, Kabisch S, Groener JB, Fleitmann AK, Herder C, Pacini G, Strassburger K, et al. (2018) An 8-week diet high in cereal fiber and coffee but free of red meat does not improve beta-cell function in patients with type 2 diabetes mellitus: a randomized controlled trial. Nutr Metab (Lond) 15: 90. doi: 10.1186/s12986-018-0324-5
11. van Dijk AE, Olthof MR, Meeuse JC, Seebus E, Heine RJ,van Dam RM (2009) Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 32: 1023-5. doi: 10.2337/dc09-0207
12. Nicolopoulos K, Mulugeta A, Zhou A,Hyppönen E (2020) Association between habitual coffee consumption and multiple disease outcomes: A Mendelian randomisation phenome-wide association study in the UK Biobank. Clin Nutr 39: 3467-3476. doi: 10.1016/j.clnu.2020.03.009
13. Nordestgaard AT, Thomsen M,Nordestgaard BG (2015) Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study. Int J Epidemiol 44: 551-65. doi: 10.1093/ije/dyv083
14. Yuan S,Larsson SC (2020) An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study. Diabetologia 63: 2359-2371. doi: 10.1007/s00125-020-05253-x
15. Wong THT, Sui Z, Rangan A,Louie JCY (2018) Discrepancy in socioeconomic status does not fully explain the variation in diet quality between consumers of different coffee types. Eur J Nutr 57: 2123-2131. doi: 10.1007/s00394-017-1488-x
16. Jeon JS, Kim HT, Jeong IH, Hong SR, Oh MS, Yoon MH, Shim JH, Jeong JH,Abd El-Aty AM (2019) Contents of chlorogenic acids and caffeine in various coffee-related products. J Adv Res 17: 85-94. doi: 10.1016/j.jare.2019.01.002
17. Restuccia D, Spizzirri UG, Parisi OI, Cirillo G,Picci N (2015) Brewing effect on levels of biogenic amines in different coffee samples as determined by LC-UV. Food Chem 175: 143-50. doi: 10.1016/j.foodchem.2014.11.134
18. Sirota R, Gorelik S, Harris R, Kohen R,Kanner J (2013) Coffee polyphenols protect human plasma from postprandial carbonyl modifications. Mol Nutr Food Res 57: 916-9. doi: 10.1002/mnfr.201200557
19. team P-U (2020) Pan-UKB. https://pan.ukbb.broadinstitute.org.
20. Kanai M, Akiyama M, Takahashi A, Matoba N, Momozawa Y, Ikeda M, Iwata N, Ikegawa S, Hirata M, Matsuda K, et al. (2018) Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat Genet 50: 390-400. doi: 10.1038/s41588-018-0047-6
21. Canela-Xandri O, Rawlik K,Tenesa A (2018) An atlas of genetic associations in UK Biobank. Nat Genet 50: 1593-1599. doi: 10.1038/s41588-018-0248-z
22. Yengo L, Sidorenko J, Kemper KE, Zheng Z, Wood AR, Weedon MN, Frayling TM, Hirschhorn J, Yang J,Visscher PM (2018) Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry. Hum Mol Genet 27: 3641-3649. doi: 10.1093/hmg/ddy271
23. Lu Y, Day FR, Gustafsson S, Buchkovich ML, Na J, Bataille V, Cousminer DL, Dastani Z, Drong AW, Esko T, et al. (2016) New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk. Nat Commun 7: 10495. doi: 10.1038/ncomms10495
24. Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW, Payne AJ, Steinthorsdottir V, Scott RA, Grarup N, et al. (2018) Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet 50: 1505-1513. doi: 10.1038/s41588-018-0241-6
25. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105-16. doi: 10.1038/ng.520
26. Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, Ganna A, Chen J, Buchkovich ML, Mora S, et al. (2013) Discovery and refinement of loci associated with lipid levels. Nat Genet 45: 1274-1283. doi: 10.1038/ng.2797
27. Shah S, Henry A, Roselli C, Lin H, Sveinbjörnsson G, Fatemifar G, Hedman ÅK, Wilk JB, Morley MP, Chaffin MD, et al. (2019) Genome-wide association study provides new insights into the genetic architecture and pathogenesis of heart failure. bioRxiv.
28. Roselli C, Chaffin MD, Weng LC, Aeschbacher S, Ahlberg G, Albert CM, Almgren P, Alonso A, Anderson CD, Aragam KG, et al. (2018) Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet 50: 1225-1233. doi: 10.1038/s41588-018-0133-9
29. Nikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S, Saleheen D, Kyriakou T, Nelson CP, Hopewell JC, et al. (2015) A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet 47: 1121-1130. doi: 10.1038/ng.3396
30. Woo D, Falcone GJ, Devan WJ, Brown WM, Biffi A, Howard TD, Anderson CD, Brouwers HB, Valant V, Battey TW, et al. (2014) Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage. Am J Hum Genet 94: 511-21. doi: 10.1016/j.ajhg.2014.02.012
31. Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng YC, Fornage M, Ikram MA, Malik R, Bevan S, et al. (2012) Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol 11: 951-62. doi: 10.1016/s1474-4422(12)70234-x
32. Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh PR, Duncan L, Perry JR, Patterson N, Robinson EB, et al. (2015) An atlas of genetic correlations across human diseases and traits. Nat Genet 47: 1236-41. doi: 10.1038/ng.3406
33. Zhu X, Feng T, Tayo BO, Liang J, Young JH, Franceschini N, Smith JA, Yanek LR, Sun YV, Edwards TL, et al. (2015) Meta-analysis of correlated traits via summary statistics from GWASs with an application in hypertension. Am J Hum Genet 96: 21-36. doi: 10.1016/j.ajhg.2014.11.011
34. Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM,Lee JJ (2015) Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4: 7. doi: 10.1186/s13742-015-0047-8
35. Yu G, Wang LG, Han Y,He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16: 284-7. doi: 10.1089/omi.2011.0118
36. Bowden J, Davey Smith G,Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44: 512-25. doi: 10.1093/ije/dyv080
37. Pierce BL,Burgess S (2013) Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol 178: 1177-84. doi: 10.1093/aje/kwt084
38. Morrison J, Knoblauch N, Marcus JH, Stephens M,He X (2020) Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics. Nat Genet 52: 740-747. doi: 10.1038/s41588-020-0631-4
39. Génin E (2020) Missing heritability of complex diseases: case solved? Hum Genet 139: 103-113. doi: 10.1007/s00439-019-02034-4
40. Hubacek JA, Pikhart H, Peasey A, Malyutina S, Pajak A, Tamosiunas A, Voevoda M, Holmes MV,Bobak M (2019) The association between the FTO gene variant and alcohol consumption and binge and problem drinking in different gene-environment background: The HAPIEE study. Gene 707: 30-35. doi: 10.1016/j.gene.2019.05.002
41. Mitra SR, Tan PY,Amini F (2018) Effect of FTO rs9930506 on obesity and interaction of the gene variants with dietary protein and vitamin E on C-reactive protein levels in multi-ethnic Malaysian adults. J Hum Nutr Diet 31: 758-772. doi: 10.1111/jhn.12593
42. Liu Y, Liang G, Xu H, Dong W, Dong Z, Qiu Z, Zhang Z, Li F, Huang Y, Li Y, et al. (2021) Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. Cell Metab 33: 1221-1233.e11. doi: 10.1016/j.cmet.2021.04.001
43. Bossini-Castillo L, de Kovel C, Kallberg H, van 't Slot R, Italiaander A, Coenen M, Tak PP, Posthumus MD, Wijmenga C, Huizinga T, et al. (2015) A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides. Ann Rheum Dis 74: e15. doi: 10.1136/annrheumdis-2013-204591
44. Burgess S, Dudbridge F,Thompson SG (2016) Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med 35: 1880-906. doi: 10.1002/sim.6835
45. Bowden J, Davey Smith G, Haycock PC,Burgess S (2016) Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol 40: 304-14. doi: 10.1002/gepi.21965
46. Yuan S, Carter P, Mason AM, Burgess S,Larsson SC (2021) Coffee Consumption and Cardiovascular Diseases: A Mendelian Randomization Study. Nutrients 13. doi: 10.3390/nu13072218
47. Kim HJ, Cho S, Jacobs DR, Jr.,Park K (2014) Instant coffee consumption may be associated with higher risk of metabolic syndrome in Korean adults. Diabetes Res Clin Pract 106: 145-53. doi: 10.1016/j.diabres.2014.07.007
48. Zhou A,Hyppönen E (2019) Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: a prospective analysis of up to 347,077 individuals and 8368 cases. Am J Clin Nutr 109: 509-516. doi: 10.1093/ajcn/nqy297